David Berry, Valo Health CEO

No­vo signs up for near­ly a dozen car­diometa­bol­ic pro­grams out of Va­lo Health

No­vo Nordisk will broad­en its car­diometa­bol­ic pipeline by pair­ing up with ma­chine learn­ing and drug dis­cov­ery start­up Va­lo Health in a deal that builds on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.